On-target restoration of a split T cell-engaging antibody for precision immunotherapy

The restriction of appropriate tumour-specific antigens is a current limitation for T cell-engaging immunotherapy. Here, the authors have designed a new system constituted by two halve antibodies, which engage T cells once binding to two different antigens, to specifically eliminate double positive...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Agnes Banaszek, Thomas G. P. Bumm, Boris Nowotny, Maria Geis, Kim Jacob, Matthias Wölfl, Johannes Trebing, Kirstin Kucka, Dina Kouhestani, Tea Gogishvili, Bastian Krenz, Justina Lutz, Leo Rasche, Dirk Hönemann, Hannes Neuweiler, Julia C. Heiby, Ralf C. Bargou, Harald Wajant, Hermann Einsele, Gert Riethmüller, Gernot Stuhler
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Nature Portfolio 2019-11-01
Saila:	Nature Communications
Sarrera elektronikoa:	https://doi.org/10.1038/s41467-019-13196-0
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!